‪#‎SSc16‬ – Exclusive Interview with Colin Meyer, Reata Pharmaceuticals

Recent Posts

• High DNA mutation rate in SSc cells may promote cancer: Study
• Autoantibodies linked to organ damage in SSc overlap syndrome
• My scleroderma diagnosis journey: What a long, strange trip it’s been
• Cool Comedy, Hot Cuisine raises $1.3M+ for scleroderma research
• CAL101 treatment for scarring safe, well tolerated in Phase 1 trial
• Low ‘good’ cholesterol levels linked to more severe SSc-ILD
• Chest CT scan before transplant may predict survival after: Study
• SRF announces lineup for Cool Comedy, Hot Cuisine fundraiser
• Immune system’s toll-like receptor 8 may be SSc therapeutic target
• Certa’s SSc treatment candidate FT011 now known as asengeprast